Li Xiao-Fei, Zhou Fang-Jian, Qiu Shao-Peng, Liu Zhuo-Wei, Wu Rong-Pei, Huang Kai, Mei Hua
Department of Urology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, 510080, PR China.
Ai Zheng. 2004 Sep;23(9):1074-6.
BACKGROUND & OBJECTIVE: Renal cell carcinoma (RCC) might involve the renal vein, and form tumor thrombus extending into the vena cava or the right atrium. Treating RCC with vena cava involvement is difficult in clinical practice. Radical nephrectomy with complete tumor thrombus removal could result in good outcomes for RCC patients with vena cava thrombi. This paper was to report our experiences on treating RCC with vena cava thrombi.
From May 1995 to Oct. 2003, radical nephrectomy plus vena cava thrombus removal was performed in 14 RCC patients. Clinical records, including preoperative diagnosis, operation pattern, and prognosis, of these 14 patients were analyzed retrospectively.
Vena cava thrombi were detected in 9 patients, and missed in 5 patients by ultrasonography. CT scan revealed vena cava thrombi in 12 of 14 patients. MRI has been performed in 8 patients, and clearly demonstrated extent of the thrombus. Twelve cases of tumor thrombi within infrahepatic vena cava, 1 within intrahepatic subphrenic vena cava, and 1 within supraphrenic vena cava. The patients have been followed up for 6-70 months after surgery. Thirteen patients survived with disease-free, and 1 patient (stage IIIc) died of cancer 23 months after surgery.
Vena cava thrombi in patients with RCC could be detected on CT scan and ultrasonography. MRI is more accurate than CT,and ultrasonography in delineating extent of the thrombus. Radical nephrectomy plus vena cava thrombus removal could achieve long-term survival for patients with localized RCC and vena cava thrombi.
肾细胞癌(RCC)可能累及肾静脉,并形成肿瘤血栓延伸至下腔静脉或右心房。在临床实践中,治疗合并腔静脉受累的肾细胞癌具有挑战性。根治性肾切除术并完全清除肿瘤血栓可为合并腔静脉血栓的肾细胞癌患者带来良好预后。本文旨在报告我们治疗合并腔静脉血栓的肾细胞癌的经验。
1995年5月至2003年10月,对14例肾细胞癌患者实施了根治性肾切除术加腔静脉血栓清除术。回顾性分析这14例患者的临床记录,包括术前诊断、手术方式及预后。
超声检查发现9例患者存在腔静脉血栓,5例漏诊。CT扫描显示14例患者中有12例存在腔静脉血栓。8例患者进行了MRI检查,清晰显示了血栓范围。12例肿瘤血栓位于肝下腔静脉内,1例位于肝内膈下腔静脉内,1例位于膈上腔静脉内。患者术后随访6至70个月。13例患者无病存活,1例(Ⅲc期)患者术后23个月死于癌症。
肾细胞癌患者的腔静脉血栓可通过CT扫描和超声检查发现。MRI在描绘血栓范围方面比CT和超声更准确。根治性肾切除术加腔静脉血栓清除术可为局限性肾细胞癌合并腔静脉血栓的患者实现长期生存。